Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2014; 20(2): 414-424
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.414
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.414
Table 3 Contraindications to liver transplantation in human immunodeficiency virus positive patient
Condition | Comment |
Progressive multifocal leukoencephalopathy | |
Cryptosporidiosis | Chronic intestinal > 1 mo duration |
Lymphoma | Primary CNS |
Visceral Kaposi’s sarcoma | Cutaneous KS considered if remission with immune reconstitution and no active/vascular residual cutaneous lesions on physical exam and chest CT scan |
Encephalopathy, HIV-related | Unless diagnosed prior to HAART and resolved on HAART with marked improvement in mental status and increased CD4+ T-cell count and no evidence of progression of CNS disease and are otherwise considered eligible from a functional standpoint |
- Citation: Congly SE, Doucette KE, Coffin CS. Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation. World J Gastroenterol 2014; 20(2): 414-424
- URL: https://www.wjgnet.com/1007-9327/full/v20/i2/414.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i2.414